Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
Assessing advances in three decades of clinical antiretroviral therapy on the HIV-1 reservoir.
Impact of Dolutegravir plus Lamivudine as First-Line Antiretroviral Treatment on HIV-1 Reservoir and Inflammatory Markers in Peripheral Blood.
Host genetic and immune factors drive evasion of HIV-1 pathogenesis in viremic non-progressors.
Protein Nanoparticles for Targeted SARS-CoV-2 Trapping and Neutralization.
Sustained aviraemia despite anti-retroviral therapy non-adherence in male children following in utero hiv transmission.
Targeting Viral Transcription for HIV Cure Strategies.
Exploring the HIV-1 Rev Recognition Element (RRE)-Rev Inhibitory Capacity and Antiretroviral Action of Benfluron Analogs.
Understanding the neurological implications of acute and long COVID using brain organoids.
Caecum OX40+CD4 T-cell subset associates with mucosal damage and key markers of disease in treated HIV-infection.
Impact of obefazimod on viral persistence, inflammation, and immune activation in people with HIV on suppressive antiretroviral therapy.